Urology Doctors in Washington, NC Accepting Medicare

3 Urology doctors found. Showing 1 - 3

Dr. Michael Brett Crawford, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1202 Brown Street, Washington, NC 27889 Phone: 252-946-0136    Fax: 252-946-0189

Dr. Michael J Lobos, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1202 Brown Street, Washington, NC 27889 Phone: 252-946-0136    Fax: 252-746-0189

Steven Edward Marks, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1202 Brown St, Washington, NC 27889 Phone: 252-946-0136

News Archive

Intensive glucose control associated with reduced risk of albuminuria

A review of data from seven clinical trials suggests that intensive glucose control is associated with reduced risk of microalbuminuria and macroalbuminuria (conditions characterized by excessive levels of protein in the urine usually resulting from damage to the filtering units of the kidneys), according to a report published in the May 28 issue of Archives of Internal Medicine, a JAMA Network publication.

Curemark closes $6.5 million Series A round of funding

Curemark, a privately held drug research and development company, announced today that it has closed a $6.5M Series A round of funding.

Researchers find new risk factor for early-onset dementia

Examining brain tissue from over 500 individuals in 11 countries, researchers from the University of Pennsylvania School of Medicine and the Children's Hospital of Philadelphia, and colleagues found a new risk factor for the second-most-common cause of early-onset dementia after Alzheimer's disease.

Blood clot discovery could lead to development of better treatments for blood diseases

Scientists have discovered new ways in which the body regulates blood clots, in a discovery which could one day lead to the development of better treatments that could help prevent and treat conditions including heart diseases, stroke and vascular dementia.

Capstone Therapeutics reaches overall progress in AZX100 Phase 2a clinical trials for keloid scarring

Capstone Therapeutics announced today that participating subjects have reached the planned twelve-month timepoint in the first of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. Data analysis for these subjects is underway. Per protocol and the original clinical development plan, results of the two keloid scarring trials will be pooled for analytical purposes and are scheduled for release during 4Q2010.

Read more Medical News

› Verified 9 days ago